ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Akcea Therapeutics Inc.
18.17
0.0000
成交量：
- -
成交額：
- -
市值：
18.49億
市盈率：
-32.26
高：
18.17
開：
18.17
低：
18.17
收：
18.17
52周最高：
21.71
52周最低：
8.00
股本：
1.02億
流通股本：
1,793.29萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.5632
每股收益(LYR):
0.2936
淨資產收益率：
-9.80%
總資產收益率：
-5.95%
市淨率：
3.86
市盈率(LYR):
61.89
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Akcea Therapeutics Inc.
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.akceatx.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Akcea治療公司最初於2014年12月成立於特拉華州，為Ionis Pharmaceuticals, Inc.的全資子公司，並於2015年創立了自己的業務。該公司是一家後期生物製藥公司，專註於開發和商業化藥物以治療由脂質障礙引起的嚴重心臟代謝疾病的患者。該公司的目標是成為首屈一指的為治療不足的脂質疾病提供治療的公司。該公司正在推進四種具有治療多種疾病潛力的新型藥物的成熟渠道。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AKCA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"AKCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKCA\",,,,,undefined,":{"symbol":"AKCA","market":"US","secType":"STK","nameCN":"Akcea Therapeutics Inc.","latestPrice":18.17,"timestamp":1602273600000,"preClose":18.17,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":17932931,"shares":101759772,"eps":-0.563165,"marketStatus":"停牌","change":0,"latestTime":"10-09 16:00:00 EDT","open":18.17,"high":18.17,"low":18.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.563165,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1500004800000,"exchange":"NASDAQ","adjPreClose":18.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKCA\",,,,,undefined,":{"symbol":"AKCA","floatShares":17932931,"roa":"-5.95%","roe":"-9.80%","lyrEps":0.2936,"shares":101759772,"dividePrice":0,"high":18.17,"amplitude":0,"preClose":18.17,"low":18.17,"week52Low":8,"pbRate":"3.86","week52High":21.705,"institutionHeld":0,"latestPrice":18.17,"eps":-0.563165,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.563165,"open":18.17,"prevYearClose":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKCA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-14","symbol":"AKCA","reason":null,"defaultRemindTime":1602682200000,"announcedDate":"2020-10-06","type":"delisting","dateTimestamp":1602648000000},{"market":"US","date":"2020-10-13","symbol":"AKCA","reason":null,"defaultRemindTime":1602595800000,"announcedDate":"2020-10-06","type":"delisting","dateTimestamp":1602561600000},{"market":"US","date":"2020-08-04","symbol":"AKCA","fiscalQuarterEnding":"2020/06","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1596513600000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2020-05-05","symbol":"AKCA","fiscalQuarterEnding":"2020/03","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1588651200000,"reportTimeType":"post","actualEps":-0.42},{"date":"2020-02-25","symbol":"AKCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":2.1,"defaultRemindTime":1582664400000,"name":null,"time":"盤後","dateTimestamp":1582606800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKCA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKCA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKCA","date":"2020-10-12","current":-32.264079,"percent":0.118727,"low":-58.203477,"twenty":-28.017058,"median":-19.02921,"eighty":-15.189182,"high":44.622078,"avg":-18.595705,"sd":17.057228,"marketCap":1848975057},"quantilePoints":[],"updateTime":1774745412016},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.akceatx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Akcea治療公司最初於2014年12月成立於特拉華州，為Ionis Pharmaceuticals, Inc.的全資子公司，並於2015年創立了自己的業務。該公司是一家後期生物製藥公司，專註於開發和商業化藥物以治療由脂質障礙引起的嚴重心臟代謝疾病的患者。該公司的目標是成為首屈一指的為治療不足的脂質疾病提供治療的公司。該公司正在推進四種具有治療多種疾病潛力的新型藥物的成熟渠道。","exchange":"NASDAQ","name":"Akcea Therapeutics Inc.","nameEN":"Akcea Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AKCA\",market:\"US\",,,undefined,":null}}